drugset / Trial / NCT05004610

Hypertonic Lactate After Cardiac Arrest

NCT05004610

Phase 2 Recruiting 125 enrolled Erasme University Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The study is intended to test the hypothesis that sodium lactate infusion after resuscitation from a cardiac arrest will decrease the magnitude of brain damage, as measured by the serum biomarker concentration of NSE.

Timeline

Start
2025-02-19
Primary completion
2027-12-31
Completion
2028-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Lactate Other / unclassified Intravenous